MIF
GSK icon

Mediolanum International Funds’s GSK GSK Stock Holding History

Mediolanum International Funds’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-289,687
Closed -$5.96M – 461
2024
Q3 		$5.96M Buy
+289,687
New +$11.9M 0.08% 226

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Mediolanum International Funds's GSK Position: Q4 2024 in Review

Mediolanum International Funds sold out of GSK (GSK) in Q4 2024, closing a stake of 289,687 shares — an estimated $5.96M sold.

Mediolanum International Funds first reported a position in GSK in Q3 2024 and held it in 1 quarter. The position peaked at $5.96M in Q3 2024. 848 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

  • Mediolanum International Funds reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
  • Mediolanum International Funds sold 289,687 GSK shares in Q4 2024, an estimated $5.96M.
  • Mediolanum International Funds first reported a position in GSK in Q3 2024 and held it in 1 quarter.
  • Mediolanum International Funds's GSK position peaked at $5.96M in Q3 2024.
  • 848 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Mediolanum International Funds's 13F filing for Q4 2024, filed 23 Jan 2025.